Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients

scientific article published on 24 September 2003

Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10096-003-0998-Z
P698PubMed publication ID14508660

P50authorYuen Kwok-yungQ8060280
Ivan Fan Ngai HungQ73401116
P2093author name stringV C C Cheng
P C Y Woo
S K P Lau
W C Yam
W C Cheung
S P Y Wong
P2860cites workImmunorestitution disease involving the innate and adaptive responseQ33958197
Paradoxical tuberculous reactions in HIV-infected patients.Q34239416
Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patientsQ35014100
Peripartum Tuberculosis as a Form of Immunorestitution DiseaseQ35126185
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.Q39461069
Paradoxical worsening of tuberculosis in HIV-infected personsQ39573447
Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosisQ40893278
Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapyQ44423968
Paradoxical reactions in HIV and pulmonary TB.Q44584678
Immunorestitution diseases in patients not infected with HIV.Q44596861
Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapyQ45756500
Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.Q47876081
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.Q54011836
Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989-1999.Q64971039
Lymph node tuberculosis: A comparison of various methods of treatmentQ67057559
Study of paradoxical response to chemotherapy in tuberculous pleural effusionQ71337463
Paradoxical worsening in tuberculosis during therapy in an HIV-infected patientQ71787270
Paradoxical presentation of intracranial tuberculomas after chemotherapy in a patient with AIDSQ72365359
Paradoxical subcutaneous tuberculous abscessQ73328401
Clinico-diagnostic experience with tuberculous lymphadenitis in Saudi ArabiaQ73417714
Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapyQ73451530
Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosisQ77220423
Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapyQ77470051
Paradoxical reaction to the treatment of tuberculosis uncovering previously silent meningeal diseaseQ77714078
P433issue10
P304page(s)597-602
P577publication date2003-09-24
P1433published inEuropean Journal of Clinical Microbiology & Infectious DiseasesQ15754378
P1476titleRisk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients
P478volume22

Reverse relations

cites work (P2860)
Q39978282A Case of Obstructive Jaundice Caused by Paradoxical Reaction during Antituberculous Chemotherapy for Abdominal Tuberculosis
Q41004952A rare association of tuberculous longitudinally extensive transverse myelitis (LETM) with brain tuberculoma
Q41900585Acute respiratory distress during paradoxical reaction to antituberculous therapy in an 8-month-old child
Q36420403Cerebral tuberculoma as a manifestation of paradoxical reaction in patients with pulmonary and extrapulmonary tuberculosis
Q38008219Clinical and radiological outcomes after conservative treatment of TB spondylitis: is the 15 years' follow-up in the MRC study long enough?
Q37165276Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis
Q36238260Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome
Q36124569Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study.
Q42012583Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
Q41841466Disseminated tuberculosis with varied paradoxical reactions
Q64053032Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
Q92616209Frequency, clinical characteristics, risks, and outcomes of Paradoxical upgrading reactions during anti-tuberculosis treatment in tuberculous lymphadenitis
Q80990764Illness of Immune Reconstitution: Recognition and Management
Q36141214Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals
Q44282700Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis
Q31020831Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis
Q34451405Kinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with tuberculous meningitis
Q45342394Loss of vision and hearing in a case of cervical lymph node tuberculosis: A rare paradoxical reaction
Q42388176Multiresistant Tuberculosis and Its Paradoxical Manifestations.
Q36444976Paradoxical Manifestation is Common in HIV-negative Tuberculous Meningitis
Q89735582Paradoxical Reaction In The Form Of New Pulmonary Mass During Anti-Tuberculosis Treatment: A Case Series And Literature Review
Q55502066Paradoxical Reaction in a Patient with Co-Occurring Tuberculous Meningitis and Pott's Disease.
Q47931604Paradoxical reaction in the form of pleural effusion after onset of anti-tuberculous medication for tubercular lymphadenitis.
Q36058313Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis
Q44703613Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients.
Q93163910Paradoxical reactions in ocular tuberculosis
Q40376849Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report
Q39895978Paradoxical response in spinal tuberculosis: Lessons learnt
Q38797570Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy
Q33882949Paralysis developing as a paradoxical response during the treatment for tuberculous spondylitis: a case report
Q37634686Pathogenesis and immune response in tuberculous meningitis
Q35554256Radiological Follow-up of a Cerebral Tuberculoma with a Paradoxical Response Mimicking a Brain Tumor
Q37041179Severe paradoxical reaction requiring tracheostomy in a human immunodeficiency virus (HIV)-negative patient with cervical lymph node tuberculosis
Q41958549Systemic lymph node tuberculosis presenting with an aseptic psoas abscess caused by a paradoxical reaction after nine months of antituberculosis treatment: a case report
Q37772355The chemotherapy of tuberculous lymphadenopathy in children
Q30425754The dual face of central nervous system tuberculosis: a new Janus Bifrons?
Q24809668The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review
Q92443922Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients
Q28749315Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
Q83970451[Immune reconstitution syndrome]

Search more.